相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
从原料到标记,打造属于中国自己的流式抗体品牌推荐!临床医学研究优质期刊,覆盖29个领域五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 库存:
999
- 英文名:
MK-0812 Succinate
- CAS号:
851916-42-2
- 保质期:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 供应商:
北京索莱宝科技有限公司
- 保存条件:
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
- 规格:
1mg/25mg/10mg/5mg/2mg
| 规格: | 1mg | 产品价格: | ¥710.00 |
|---|---|---|---|
| 规格: | 25mg | 产品价格: | ¥5710.00 |
| 规格: | 10mg | 产品价格: | ¥2870.00 |
| 规格: | 5mg | 产品价格: | ¥1790.00 |
| 规格: | 2mg | 产品价格: | ¥1136.00 |
| CAS | 851916-42-2 |
| 英文名称 | MK-0812 Succinate |
| 分子式 | C28H40F3N3O7 |
| 分子量 | 587.63 |
| 规格 | 1mg ; 2mg ; 5mg ; 10mg ; 25mg |
| 溶解性 | Soluble in DMSO ≥3mg/mL |
| 纯度 | ≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
| 运输条件 | 冷藏运输 |
| SMILES | CC(C)[C@@]1(CC[C@H](C1)[NH2+][C@H]2CCOC[C@H]2OC)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F.C(CC(=O)[O-])C(=O)O |
| InChIKey | WPPJJJUIDYHHSM-PXUYIWLPSA-N |
| InChI | InChI=1S/C24H34F3N3O3.C4H6O4/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27;5-3(6)1-2-4(7)8/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3;1-2H2,(H,5,6)(H,7,8)/t18-,20+,21-,23+;/m1./s1 |
| PubChem CID | 60196412 |
| 靶点 | CCR |
| 通路 | Immunology & Inflammation;GPCR & G Protein |
| 背景说明 | MK-0812 Succinate 是一种有效的选择性 CCR2 拮抗剂。 |
| 生物活性 | MK-0812 Succinate is a potent and selective CCR2 antagonist with high affinity at CCR2.[1-2] |
| In Vitro | MK-0812 is a potent and selective CCR2 antagonist[1]. MK-0812 completely blocks all MCP-1 mediated response in a concentration dependent manner, with an IC50 of 3.2 nM. This value is similar to the potency observed for the inhibition of 125I-MCP-1 binding by MK-0812 on isolated monocytes (IC50 4.5 nM). In fact, MK-0812 not only completely blocks the shape change response to exogenous MCP-1, but also results in a monocyte forward scatter measurement below unstimulated or basal levels. The addition of MK-0812 to rhesus blood also inhibits MCP-1 induced monocyte shape change. The IC50 for MK-0812 in whole blood assays is 8 nM[2] |
| In Vivo | MK-0812 (30 mg/kg, p.o.) reduces the frequency of Ly6G-Ly6Chi monocytes in the peripheral blood, while no impact on circulating Ly6G+Ly6C+ neutrophil frequency is observed. In addition, MK-0812 treatment causes a dose-dependent reduction in circulating Ly6Chi monocytes and a corresponding elevation in the CCR2 ligand CCL2[1]. MK-0812 is administered by continuous i.v. infusion to maintain a constant level of the drug in blood[2]. |
| 动物实验 | Mice[1]Female BALB/c mice are used between 8 and 10 weeks of age. SCH563705 or MK-0812 are administered in a 0.4% methylcellulose (MC) solution by 30 mg/kg oral gavage (p.o.). Two hours later, the frequency of CD11b+Ly6G-Ly6Chi monocytes and CD11b+Ly6G+Ly6C+ neutrophils is determined by flow cytometry[1]. |
| 数据来源文献 | [1]. Min SH, et al. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis.Biochem Biophys Res Commun. 2010 Jan 1;391(1):1080-6. [2]. Wisniewski T, et al. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.J Immunol Methods. 2010 Jan 31;352(1-2):101-10. |
| 单位 | 瓶 |
| 表格1 | |*|1mg|5mg|10mg|$$|1mM|1.7018mL|8.5088mL|17.0175mL|$$|5mM|0.3404mL|1.7018mL|3.4035mL|$$|10mM|0.1702mL|0.8509mL|1.7018mL| |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验用氧来氧化琥珀酸为延胡索酸的酶类。琥珀酸脱氢酶稳定地存在于线粒体内膜上,不能以可溶性的形态被提取,与细胞色素等密切结合,形成将电子传递给氧的复合酶系,因此很早以来就对琥珀酸氧化酶系进行了研究。作为成分,尚有 FAD、非铁血红素、辅酶 Q、细胞色素 b、 c、 c、 a、铜。氧化 1分子琥珀酸,可从 ADP和无机磷酸偶联生成二分子的 ATP。
琥珀酸脱氢酶 succinate dehydrogenase
系催化琥珀酸转化为延胡索酸的脱氢反应的酶( E. C. 1. 3. 99. 1)。生理的电子受体还不太清楚。属于黄素酶类,每约 20— 30万分子量中含有 1个 FAD, CH2 — COOH HOOCCHFAD和酶蛋白以共价键结合。酶中尚含有数个原子非铁血红素。 Fg( CN) 63-和吩嗪( phenagine)是它有效的人工电子受体。是巯( SH)酶的一种。可受丙二酸和草酰乙酸的拮抗性抑制,此酶存在于线粒体内膜和细菌的细胞膜上,与膜结构
上海西唐生物科技有限公司 021-55229872, 65333639 www.westang.com 大鼠 MK(Midkine)ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗大鼠 Midkine 单抗包被于酶标板上,标准品和样品中的 Midkine 与单抗结合,加入生物素化的抗大鼠 Midkine ,形成免疫复合












